GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QHSLab Inc (STU:E1Z) » Definitions » Cyclically Adjusted Price-to-FCF

QHSLab (STU:E1Z) Cyclically Adjusted Price-to-FCF : (As of Sep. 22, 2024)


View and export this data going back to 2022. Start your Free Trial

What is QHSLab Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


QHSLab Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for QHSLab's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QHSLab Cyclically Adjusted Price-to-FCF Chart

QHSLab Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

QHSLab Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of QHSLab's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, QHSLab's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QHSLab's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QHSLab's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where QHSLab's Cyclically Adjusted Price-to-FCF falls into.



QHSLab Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

QHSLab's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, QHSLab's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0.008/132.5538*132.5538
=0.008

Current CPI (Jun. 2024) = 132.5538.

QHSLab Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201409 -0.005 100.428 -0.007
201412 -0.003 99.070 -0.004
201503 -0.008 99.621 -0.011
201506 -0.011 100.684 -0.014
201509 -0.002 100.392 -0.003
201512 -0.001 99.792 -0.001
201603 -0.001 100.470 -0.001
201606 -0.002 101.688 -0.003
201609 0.000 101.861 0.000
201612 0.000 101.863 0.000
201703 0.000 102.862 0.000
201706 0.000 103.349 0.000
201709 0.000 104.136 0.000
201712 0.000 104.011 0.000
201803 0.000 105.290 0.000
201806 -0.007 106.317 -0.009
201809 -0.002 106.507 -0.002
201812 -0.001 105.998 -0.001
201903 -0.007 107.251 -0.009
201906 -0.003 108.070 -0.004
201909 -0.005 108.329 -0.006
201912 -0.007 108.420 -0.009
202003 -0.007 108.902 -0.009
202006 -0.003 108.767 -0.004
202009 -0.008 109.815 -0.010
202012 -0.005 109.897 -0.006
202103 -0.007 111.754 -0.008
202106 -0.012 114.631 -0.014
202109 -0.018 115.734 -0.021
202112 -0.017 117.630 -0.019
202203 -0.018 121.301 -0.020
202206 0.004 125.017 0.004
202209 -0.020 125.227 -0.021
202212 -0.007 125.222 -0.007
202303 0.000 127.348 0.000
202306 -0.004 128.729 -0.004
202309 0.001 129.860 0.001
202312 -0.013 129.419 -0.013
202403 0.005 131.776 0.005
202406 0.008 132.554 0.008

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


QHSLab  (STU:E1Z) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


QHSLab Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of QHSLab's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


QHSLab Business Description

Traded in Other Exchanges
Address
901 Northpoint Parkway, Suite 302, West Palm Beach, FL, USA, 33407
QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. It is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.

QHSLab Headlines

No Headlines